A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

CVRx Implantable Baroreflex Stimulator for the Treatment of Hypertension

   CVRx was founded in Minneapolis, MN in 2001 by Dr. Robert Kieval to develop an implantable system for the treatment of hypertension. CVRx’s implantable pulse generators deliver stimulation to the baroeceptors in the carotid arteries to induce a baroreflex that causes a drop in blood pressure in patients with refractory hypertension.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
2 Comments  comments 
formats

Second Sight’s Implantable Retinal Prosthesis

Second Sight Medical Products, Inc., located in Los Angeles, CA, was founded in 1998 by Alfred Mann to develop a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa. Second Sight’s Argus II Retinal Prosthesis System is intended to provide electrical stimulation of the retina to induce visual

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Second Sight’s Implantable Retinal Prosthesis  comments 
formats

EndoStim Implantable Stimulator for Treatment of Gastro-Esophageal Reflux Disease (GERD)

St. Louis, MO startup EndoStim is developing an implantable stimulator to treat gastro-esophageal reflux disease (GERD) by delivering stimulation to the lower esophageal sphincter.  The IPG is connected to an EndoStim implantable bipolar lead with electrodes that are stitched and secured into the lower esophageal sphincter muscle during laparoscopy.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EndoStim Implantable Stimulator for Treatment of Gastro-Esophageal Reflux Disease (GERD)  comments 
formats

Sicel’s Implantable Radiation Dosimeter

Sicel Technologies, Inc. was founded in 1999 and was based in Morrisville, NC. It ceased operations in 2010 after it declared bankruptcy. Sicel developed an implantable dosimeter that was 2 mm in diameter and 18 mm long, and was injected into the tumor to send back readings to an external receiver via RFID.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Sicel’s Implantable Radiation Dosimeter  comments 
formats

AIMD Companies Founded by Alfred E. Mann

Alfred E. Mann holds B.A. and M.S. degrees in physics from the University of California, Los Angeles and honorary doctorate degrees from the University of Southern California, The Johns Hopkins University, Western University and the Technion Institute (Israel), as well as, Research Professor, University of Southern California, and Adjunct Professor, Dept. of Bioengineering, University of

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on AIMD Companies Founded by Alfred E. Mann  comments 
formats

AIMD Companies Founded by Dr. Robert Fischell

Dr. Fischell received his BSME degree from Duke University and MS and Sc.D. degrees from the University of Maryland. Dr. Fischell was employed at the Johns Hopkins University where he was the Chief Engineer of the Space Department and worked on more than 50 spacecraft. His interests at Johns Hopkins then turned to the invention

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on AIMD Companies Founded by Dr. Robert Fischell  comments 
formats

AIMD Companies Founded by David R. Fischell, Ph.D.

Dr. David R. Fischell is a serial entrepreneur who has founded nine biomedical device companies in the last fifteen years. He is chairman of the Cornell University Biomedical Engineering Advisory Board, and a Fellow of the American Institute for Medical and Biological Engineering. After earning his Ph.D. in Applied Physics from Cornell University, Dr. Fischell

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on AIMD Companies Founded by David R. Fischell, Ph.D.  comments 
formats

NeuroPace’s Responsive Neurostimulator (RNS) for the Treatment of Epilepsy

NeuroPace is a privately-held company in Mountain View, CA.  Their RNS®  implantable stimulator, along with depth leads and cortical strip leads are designed for the treatment of medically refractory partial epilepsy. Unlike Cyberonics’ VNS IPGs, the RNS neurostimulator is designed to detect abnormal electrical activity in the brain and respond by delivering electrical stimulation to normalize brain activity

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

Cyberonics’ Vagus Nerve Stimulators

Cyberonics was founded in Houston, TX in 1987 to develop an implantable device for the treatment of epilepsy.  In July 1997, The FDA approved the VNS Therapy System (formerly known as the NCP® NeuroCybernetic Prosthesis System) as an adjunctive epilepsy treatment for adults and children over 12 years of age with partial onset seizures refractory to

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cyberonics’ Vagus Nerve Stimulators  comments